IT products ready for market and ones nearing commercial release punctuated the Merge Healthcare booth at the RSNA meeting. Two works-in-progress vied particularly well for the attention of visitors. One is the eFilm for iPhone, an image-enabled supplement to the electronic medical record. The second is the company’s FusionWeb Patient Access Portal, which delivers an Internet-based means for web-savvy patients to manage appointments, update records, receive appointment reminders, and view reports.
IT products ready for market and ones nearing commercial release punctuated the Merge Healthcare booth at the RSNA meeting. Two works-in-progress vied particularly well for the attention of visitors. One is the eFilm for iPhone, an image-enabled supplement to the electronic medical record. The second is the company's FusionWeb Patient Access Portal, which delivers an Internet-based means for web-savvy patients to manage appointments, update records, receive appointment reminders, and view reports.
As the name suggests, the new Merge WIP is designed for use on Apple's iPhone, but it can also work on that company's iPod touch. Development of the application grew from physicians' increasing reliance on mobile devices for communication. The goal is to allow radiologists to connect directly with their eFilm Workstations by providing a mobile link through which to view study lists and images as well as manage tasks.
The FusionWeb Patient Access Portal requires no software to be installed on a user's PC, because the portal is powered by the company's new "zero-client" FusionWeb technology. This zero-client technology taps into web-based software to do the heavy lifting behind jobs. eFilm Workstations Building on its zero-client technology, Merge showcased its Cedara WebAccess. The zero-client web platform brings images into the EMR by allowing their wide area distribution via local health information exchanges (HIEs) and regional health information organizations. eFilm Workstations Cedara WebAccess uses a standards-based approach to integrate data from multiple clinical repositories without the need for expensive proprietary interfaces or data duplication. The images and results are seamlessly delivered to clinicians, according to Merge, as part of the patient's chart in an EMR or HIE portal. This portal can be opened using desktop or tablet computers, as well as smart phones, such as an iPhone or a BlackBerry. MergeCOM-3 toolkits are also available for software development in both DICOM and HL7 standards. eFilm Workstations Rounding out the Merge exhibit was technology already proven in the marketplace, although not by Merge. Through its corporate acquisition of Confirma, completed Sept. 1, 2009, Merge now has in its portfolio the CADstream family of computer-assisted detection products for the analysis and interpretation of breast and prostate MR. Joining enhancements of these applications at the RSNA meeting will be an application designed specifically for the liver. This application features automated 3D image registration, segmentation, kinetic and diffusion-weighted imaging analysis, patient monitoring comparisons, and reporting.
AI Facilitates Nearly 83 Percent Improvement in Turnaround Time for Fracture X-Rays
December 19th 2023In addition to offering a 98.5 percent sensitivity rate in diagnosing fractures on X-ray, an emerging artificial intelligence (AI) software reportedly helped reduce mean turnaround time on X-ray fracture diagnosis from 48 hours to 8.3 hours, according to new research presented at the Radiological Society of North America (RSNA) conference.
The Reading Room: Artificial Intelligence: What RSNA 2020 Offered, and What 2021 Could Bring
December 5th 2020Nina Kottler, M.D., chief medical officer of AI at Radiology Partners, discusses, during RSNA 2020, what new developments the annual meeting provided about these technologies, sessions to access, and what to expect in the coming year.
Can an Emerging PET Radiotracer Enhance Detection of Prostate Cancer Recurrence?
December 14th 2023The use of 68Ga-RM2 PET/MRI demonstrated a 35 percent higher sensitivity rate than MRI alone for the diagnosis of biochemical recurrence of prostate cancer, according to research recently presented at the Radiological Society of North America (RSNA) conference.
RSNA 2020: Addressing Healthcare Disparities and Access to Care
December 4th 2020Rich Heller, M.D., with Radiology Partners, and Lucy Spalluto, M.D., with Vanderbilt University School of Medicine, discuss the highlights of their RSNA 2020 session on health disparities, focusing on the underlying factors and challenges radiologists face to providing greater access to care.
Can AI Improve Detection of Extraprostatic Extension on MRI?
December 4th 2023Utilizing a deep learning-based AI algorithm to differentiate between diagnostic and non-diagnostic quality of prostate MRI facilitated a 10 percent higher specificity rate for diagnosing extraprostatic extension on multiparametric MRI, according to research presented at the recent RSNA conference.
Study: Regular Mammography Screening Reduces Breast Cancer Mortality Risk by More than 70 Percent
November 30th 2023Consistent adherence to the five most recent mammography screenings prior to a breast cancer diagnosis reduced breast cancer death risk by 72 percent in comparison to women who did not have the mammography screening, according to new research findings presented at the annual Radiological Society of North America (RSNA) conference.